These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 20063996

  • 1. Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.
    Ahmed W, Rani M, Khan IA, Iqbal A, Khan KM, Haleem MA, Azim MK.
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):673-8. PubMed ID: 20063996
    [Abstract] [Full Text] [Related]

  • 2. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
    Azim MK, Ahmed W, Khan IA, Rao NA, Khan KM.
    Bioorg Med Chem Lett; 2008 May 01; 18(9):3011-5. PubMed ID: 18417344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
    Ersmark K, Nervall M, Gutiérrez-de-Terán H, Hamelink E, Janka LK, Clemente JC, Dunn BM, Gogoll A, Samuelsson B, Qvist J, Hallberg A.
    Bioorg Med Chem; 2006 Apr 01; 14(7):2197-208. PubMed ID: 16307884
    [Abstract] [Full Text] [Related]

  • 6. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V, Zimmermann M, Maass A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann-Apitius M.
    J Chem Inf Model; 2007 Apr 01; 47(5):1818-28. PubMed ID: 17727268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates.
    Fäh C, Hardegger LA, Baitsch L, Schweizer WB, Meyer S, Bur D, Diederich F.
    Org Biomol Chem; 2009 Oct 07; 7(19):3947-57. PubMed ID: 19763297
    [Abstract] [Full Text] [Related]

  • 11. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
    Gupta D, Yedidi RS, Varghese S, Kovari LC, Woster PM.
    J Med Chem; 2010 May 27; 53(10):4234-47. PubMed ID: 20438064
    [Abstract] [Full Text] [Related]

  • 12. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
    Zürcher M, Gottschalk T, Meyer S, Bur D, Diederich F.
    ChemMedChem; 2008 Feb 27; 3(2):237-40. PubMed ID: 17918177
    [No Abstract] [Full Text] [Related]

  • 13. Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.
    Ersmark K, Feierberg I, Bjelic S, Hamelink E, Hackett F, Blackman MJ, Hultén J, Samuelsson B, Aqvist J, Hallberg A.
    J Med Chem; 2004 Jan 01; 47(1):110-22. PubMed ID: 14695825
    [Abstract] [Full Text] [Related]

  • 14. [Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin].
    Rumsh LD, Mikhaĭlova AG, Mikhura IV, Prudchenko IA, Chikin LD, Mikhaleva II, Kaliberda EN, Dergousova NI, Mel'nikov EE, Formanovskiĭ AA.
    Bioorg Khim; 2008 Jan 01; 34(6):739-46. PubMed ID: 19088746
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids.
    Degliesposti G, Kasam V, Da Costa A, Kang HK, Kim N, Kim DW, Breton V, Kim D, Rastelli G.
    ChemMedChem; 2009 Jul 01; 4(7):1164-73. PubMed ID: 19437467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.